CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 90 filers reported holding CYTEK BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $138,596 | -28.9% | 25,108 | +10.0% | 0.00% | -50.0% |
| Q2 2023 | $194,917 | +8.6% | 22,824 | +16.8% | 0.00% | 0.0% |
| Q1 2023 | $179,545 | -7.4% | 19,537 | +2.9% | 0.00% | 0.0% |
| Q4 2022 | $193,929 | -27.9% | 18,994 | +4.1% | 0.00% | -33.3% |
| Q3 2022 | $269,000 | +37.9% | 18,250 | +0.3% | 0.00% | +50.0% |
| Q2 2022 | $195,000 | – | 18,190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $30,912,000 | 12.48% |
| Miura Global Management | 820,000 | $12,070,000 | 7.24% |
| RA Capital Management | 13,381,054 | $196,969,000 | 4.20% |
| HHLR ADVISORS, LTD. | 8,757,030 | $128,903,000 | 3.39% |
| Brown Capital Management | 4,406,461 | $64,863,000 | 0.91% |
| Perceptive Advisors | 1,289,534 | $18,982,000 | 0.55% |
| Hillsdale Investment Management Inc. | 344,529 | $5,072,000 | 0.46% |
| PURA VIDA INVESTMENTS, LLC | 527,164 | $7,760,000 | 0.45% |
| Parkwood LLC | 42,336 | $623,000 | 0.09% |
| PDT Partners, LLC | 31,436 | $463,000 | 0.07% |